Weekly carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed or refractory multiple myeloma (RRMM): A phase 1b study Meeting Abstract
| Authors: | Biran, N.; Di Capua Siegel, D. S.; Berdeja, J. G.; Raje, N. S.; Cornell, R. F.; Alsina, M.; Kovacsovics, T.; Fang, B.; Kimball, A.; Landgren, C. O. |
| Abstract Title: | Weekly carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed or refractory multiple myeloma (RRMM): A phase 1b study |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 428s |
| Language: | English |
| ACCESSION: | WOS:000442916003069 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.8022 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8022 -- Source: Wos |
